<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">He, Jun</style></author><author><style face="normal" font="default" size="100%">Sui, Xinbing</style></author></authors><secondary-authors></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Rethinking anti-cancer drug discovery: the evolution from polypharmacy to unified drug units</style></title><secondary-title><style face="normal" font="default" size="100%">Cancer Biology &amp;amp; Medicine</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2026</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2026-01-29 00:00:00</style></date></pub-dates></dates><elocation-id><style  face="normal" font="default" size="100%">20250641</style></elocation-id><doi><style  face="normal" font="default" size="100%">10.20892/j.issn.2095-3941.2025.0641</style></doi><volume><style face="normal" font="default" size="100%"></style></volume><issue><style face="normal" font="default" size="100%"></style></issue><abstract><style  face="normal" font="default" size="100%">You do not have access to the full text of this article, the first page of the PDF of this article appears above.</style></abstract></record></records></xml>